PhRMA
NOVEMBER 1, 2022
The United States leads the world in medicine research, development and manufacturing, and international trade delivers those medicines to patients around the globe. But trade barriers imposed in many countries impede the ability of U.S. biopharmaceutical companies to export even more American-made medicines and employ even more scientists, researchers and factory workers.
Drug Topics
NOVEMBER 1, 2022
Help protect patients by giving them the facts about getting both shots at once to save them a trip and increase rates of vaccination.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 1, 2022
Pharmacy Times is gearing up for Kidney Week (Nov. 3-6) by learning about the pharmacological role of kidney care from the president of the American Society of Nephrology.
Drug Topics
NOVEMBER 1, 2022
Phase I/II data indicate that new investigative pneumococcal conjugate vaccine shows efficacy in preventing disease in adults.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 1, 2022
Problems such as sleep deprivation, excessive sleeping, or inability to sleep regularly may be an important factor in the transition from episodic to chronic migraines.
STAT
NOVEMBER 1, 2022
A Food and Drug Administration advisory panel suggested Tuesday that the agency improve how it regulates pulse oximeters, calling for clearer labeling and more rigorous testing of the devices. The widely used instruments monitor blood oxygen levels and have been shown to work less well on patients with darker skin, possibly exacerbating health disparities in many racial and ethnic groups.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 1, 2022
The pandemic is a prime case study of what can be accomplished when science delivers. The pharmaceutical and biotech industry harnessed new technologies, collaborated in new ways, and worked at an accelerated pace to help prevent infections with SARS-CoV-2, the virus that causes Covid-19, and treat those who got the disease. Applying these new ways of working will revolutionize the understanding and treatment of diseases with no available therapies.
Pharmacy Times
NOVEMBER 1, 2022
New evidence suggests that using artificial intelligence can help individualize diagnostics and protocols, including when women should get mammograms and what medications can best suit which people.
STAT
NOVEMBER 1, 2022
The U.S. Supreme Court heard oral arguments on Monday in two cases that could eliminate race as a factor in university’s admissions processes. The precedent established in 2003, when the court ruled that race, along with other factors, could be given limited consideration in higher education admissions when necessary to achieve student body diversity, is now in jeopardy.
Pharmacy Times
NOVEMBER 1, 2022
An ASCP 2022 Annual Meeting session presenter provides an update of 6 new therapeutic agents and their appropriate use in an older adult population.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
NOVEMBER 1, 2022
In the years since the onset of the Covid-19 pandemic, many health care professionals have turned to Twitter as a way to share news and advice about public health. But Elon Musk’s takeover of Twitter, which closed last week, is raising concerns that the self-described “ free speech absolutist ” could change the social-media platform in ways that promote, rather than curb, the spread of mis- and disinformation.
Pharmacy Times
NOVEMBER 1, 2022
Herpes zoster can increase the risk of stroke, especially among patients under 40 years of age, for whom the vaccine is not typically recommended.
STAT
NOVEMBER 1, 2022
Pulse oximeters, which measure oxygen levels in blood, are one of the most widely used medical tools. They are affordable, portable, and easy to use, but they have a major drawback: Numerous studies show they are less accurate for people with darker skin. Watch this video to understand the technology behind these devices and why they are less accurate in some patients.
Pharmacy Times
NOVEMBER 1, 2022
A compound often found in citrus fruits, nobiletin, could be a less toxic and more effective treatment for cholangiocarcinoma.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
NOVEMBER 1, 2022
Leaders at Veeva believe the wording around decentralized trials has been exaggerated, and that a bigger-picture outlook is important as the pandemic winds down.
STAT
NOVEMBER 1, 2022
Pfizer’s maternal vaccine against the respiratory syncytial virus reduced the rate of severe illness in newborns by 81.8%, the company said Tuesday, meeting the goal of a pivotal study. The company said that it plans to file the data on the vaccine with regulators by the end of the year and that it expects an eight-month review.
pharmaphorum
NOVEMBER 1, 2022
In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup, Plaid, for $5.3 billion. Corporate acquisitions like these are not uncommon, but someone at the United States Department of Justice took notice of this announcement. Visa had established a stranglehold on financial transactions. The Justice Department moved to stop the acquisition on grounds that Plaid posed “a threat to this monopoly: it has been developing an innovative new solution that w
STAT
NOVEMBER 1, 2022
A Food and Drug Administration advisory committee Tuesday will take up the issue of whether pulse oximeters , the ubiquitous medical devices that became a mainstay for assessing patient oxygen levels during the Covid-19 pandemic, need to be regulated differently — or even completely reconceived — based on research showing the devices are less accurate in people with darker skin.
Drug Store News
NOVEMBER 1, 2022
Walgreens and CVS today separately announced agreements that are intended to resolve opioid-related litigation, while outlining initiatives the companies have taken to respond to the opioid crisis.
STAT
NOVEMBER 1, 2022
There was a staggering increase in requests for abortion pills through telemedicine in the months after the Supreme Court overturned Roe v. Wade , according to a new analysis. The study, published Tuesday in JAMA , was conducted by researchers at the University of Texas at Austin and Aid Access, a nonprofit online telemedicine service that provides medication that people can use to safely end a pregnancy at home.
ISPE
NOVEMBER 1, 2022
2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Trudy Patterson. Tue, 11/01/2022 - 06:49. iSpeak Blog. iSpeak. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Susan Sandler. 1 November 2022. The 2022 ISPE Annual Meeting & Expo opened with three keynote addresses exploring quality from a key FDA leader’s point of view, a major pharmaceutical company’s ongoing journey of transformation into an organiz
STAT
NOVEMBER 1, 2022
Tumble out of bed and stumble to the kitchen, pour myself a cup of ambition, and yawn and stretch and try to come to life. Jump in the shower, and the blood starts pumpin’, out on the streets, the traffic starts jumpin’, for folks like me on the job … STAT reporter Andrew Joseph here filling in for Ed, offering up some Dolly Parton along with industry headlines to cure your candy hangovers.
European Pharmaceutical Review
NOVEMBER 1, 2022
Bristol Myers Squibb (BMS) has announced Reblozyl ® (luspatercept-aamt), the first erythroid maturation agent, showed improvement in red blood cell transfusion independence (RBC-TI) and haemoglobin (Hb) increase in severely anaemic adults with very low, low or intermediate-risk myelodysplastic syndromes (MDS). Reblozyl is a first-line therapy that promotes late-stage red blood cell maturation in animal models.
Digital Pharmacist
NOVEMBER 1, 2022
November is Lung Cancer Awareness Month. Lung Cancer is the leading cause of cancer deaths in the US, and about every 2 and a half minutes, someone learns they have this disease. Many organizations are working together to defeat lung cancer and during the month of November, it’s critical to raise awareness. Background. Lung cancer is the second most common cancer in men and women and the leading cause of cancer death.
Drug Store News
NOVEMBER 1, 2022
Walgreens and CVS Health separately announced agreements intended to resolve opioid-related litigation, while outlining initiatives taken to respond to the opioid crisis.
Pharmacy Times
NOVEMBER 1, 2022
Pharmacy Times will be covering the American Society of Nephrology (ASN) Kidney Week, which will be gathering more than 10,000 professionals working on kidney health in Orlando, Florida.
PioneerRx
NOVEMBER 1, 2022
Last month, we attended the NCPA Annual Convention in Kansas City, where some of our PioneerRx Pharmacy Software users had a well-deserved time in the spotlight.
Pharmaceutical Technology
NOVEMBER 1, 2022
FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. The Excellence Rankings celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.
Drug Topics
NOVEMBER 1, 2022
Pharmacy finances can suffer if owners are tripped up by these common pitfalls.
PharmExec
NOVEMBER 1, 2022
Ten-year partnership will help Merck reduce operational costs, deliver value to patients, and optimize the healthcare professional and patient experience.
European Pharmaceutical Review
NOVEMBER 1, 2022
Researchers from Qingdao University of Science and Technology, China have used artificial intelligence (AI) to predict compounds that could neutralise baldness-causing reactive oxygen species in the scalp. Using the best candidate, they constructed a proof-of-concept microneedle patch and effectively regenerated hair on mice. Reporting in ACS’ Nano Letters , about the condition androgenic alopecia , the researchers explained that hair follicles can be damaged by androgens, inflammation or an ov
PharmaVoice
NOVEMBER 1, 2022
The Bill & Melinda Gates Medical Research Institute’s clinical development leader talks about its new licensing deal with Merck.
European Pharmaceutical Review
NOVEMBER 1, 2022
Patients 65 years or older, those with increased risk of cardiovascular disorders like heart attack or stroke, individuals who smoke or have for an extended period in the past and those at increased risk of cancer should only be given Janus kinase (JAK) inhibitors if no other suitable treatment is available, recommends the European Medicines Agency (EMA)’s Pharmacovigilance Risk Assessment Committee (PRAC).
Drug Store News
NOVEMBER 1, 2022
In his latest column, David Orgel discusses how retailers have raised the bar with creative initiatives that spotlight deep knowledge of local needs.
Expert insights. Personalized for you.
197 
Let's personalize your content